Short Interest in Aethlon Medical, Inc. (NASDAQ:AEMD) Decreases By 20.1%

Aethlon Medical, Inc. (NASDAQ:AEMD) was the target of a large drop in short interest during the month of September. As of September 15th, there was short interest totalling 182,100 shares, a drop of 20.1% from the August 31st total of 227,800 shares. Based on an average daily volume of 2,000,000 shares, the short-interest ratio is currently 0.1 days.

Analysts Set New Price Targets

Several analysts recently weighed in on AEMD shares. StockNews.com began coverage on Aethlon Medical in a research report on Sunday. They set a “sell” rating for the company. HC Wainwright decreased their price target on shares of Aethlon Medical from $10.00 to $7.00 and set a “buy” rating for the company in a research note on Monday, June 24th.

Aethlon Medical Stock Performance

Shares of Aethlon Medical stock opened at $0.47 on Friday. The company has a fifty day moving average of $0.39 and a 200-day moving average of $0.78. Aethlon Medical has a 52-week low of $0.24 and a 52-week high of $2.40. The stock has a market capitalization of $6.59 million, a price-to-earnings ratio of -0.10 and a beta of 1.72.

Aethlon Medical (NASDAQ:AEMD) last posted its quarterly earnings results on Wednesday, August 14th. The medical equipment provider reported ($0.34) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.44) by $0.10. During the same period in the previous year, the business posted ($1.30) earnings per share. On average, equities research analysts forecast that Aethlon Medical will post -1.1 earnings per share for the current fiscal year.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.